Skip to content

A randomized controlled trial for Xiao-Qing-Long Decoction in the treatment of refractory asthma

A randomized controlled trial for Xiao-Qing-Long Decoction in the treatment of refractory asthma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002783
Enrollment
Unknown
Registered
2019-11-27
Start date
2019-12-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory asthma

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Agde 18-65 years men or women, diagnosis of bronchial asthma for at least 1 year; 2. Patients conform to the diagnostic criteria of Western medicine refractory asthma; 3. Patients conform to the diagnostic standard of Chinese medicine asthma "External Cold and Internal Fluid Syndrome"; 4. Patients own good ability to read, understand and write research-related materials and comply with all trail requirements on a voluntary basis; 5. Patients voluntarily participate in research and sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients have a respiratory infection within 4 weeks; 2. Patients with chronic lung diseases require intervention or treatment such as chronic obstructive pulmonary disease, interstitial lung disease, active tuberculosis, bronchial dilation ; 3. Patients with serious primary diseases such as severe mental and psychological disorders, heart and brain vessels diseases, liver and kidney diseases, endocrine diseases, hematopoietic system diseases and malignant tumors ; 4. Patients take antibiotics within 3 months and eat yogurt or probiotics within 1 month; ? 5. Patients are unwilling or unable to change the current treatment plan; 6. Patients are known to be allergic to trail drugs or a certain Chinese medicine of this study; 7. Women are breastfeeding, pregnant or preparing for pregnancy; 8. Patients have more than 15 packs per year of smoking history ; 9. Patients have participated in other clinical studies in the past six months.

Design outcomes

Primary

MeasureTime frame
Asthma Control Test(ACT) score;

Secondary

MeasureTime frame
Pulmonary function(FEV1, FEV1/FVC, daytime and night peak expiratory flow(PEF));Average daily use of drugs that relieve asthma;Curative effect of TCM syndrome;Asthma Quality of Life Questionnaire(AQLQ);Changes in the composition of intestinal flora in the faeces of subjects;

Countries

China

Contacts

Public ContactQingsong Huang

Hospital of Chengdu University of Traditional Chinese Medicine

738118482@qq.com+86 13880336152

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026